Novo Nordisk A/S stock price
NVO
#63

41,41 $
  

6.87%

Novo Nordisk A/S Info

Capitalización de mercado
183,7B $

6.87%

Volumen diario
962,56M $
Tipo de activo
Acciones
Empleados
78387
Fundado
Dec 21, 1923
Exchange principal
New York Stock Exchange
Número CIK
0000353278

Datos de acciones tokenizadas

Prom. del precio tokenizado
41,95 $
Diferencia de precio
+0,5399 $(+1.30%)
Capitalización de mercado tokenizada
3,43M $

8.65%

Volumen tokenizado (24h)
880,06K $

3.53%

Emisores
Contratos
Exploradores
Convertidor de NVO a USD
NVO
USD
Rendimiento de precios
Baja
38,22 $
Alta
41,41 $

Cargando datos

Por favor, espera, estamos cargando datos de gráficos

Novo Nordisk A/S comunidad

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Datos de Precio en vivo

The current price of Novo Nordisk A/S in the market is 41,41 $, with a 24-hour trading volume of 962,56M $. The asset's market cap is 183,7B $, after moving 6.88% in the last day.

Tokenized Novo Nordisk A/S is trading at 41,95 $, with a tokenized market cap of 3,43M $ and a 24-hour trading volume of 880,06K $. The tokenized asset has moved 8.65% in the past 24 hours.